Rifapentine: all 46 studies that test it
Page 1 of 1. Open to participants first (10), then studies with results posted, then the rest; newest registration first within each.
- A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB)Not yet recruitingNCT07595042Phase 2
- Short-Course Anti-tuberculosis Regimens for Mild Spinal TuberculosisNot yet recruitingNCT06917495Phase 2
- Shorter and Safer Treatment Regimens for Latent TBRecruitingNCT06498414Phase 2/3
- Dolutegravir Pharmacokinetics During Weekly Rifapentine/Isoniazid for TB PreventionRecruitingNCT06281834Phase 1
- Shortened Regimen for Drug-susceptible TB in ChildrenRecruitingNCT06253715Phase 3
- A Novel Therapy With a 1-Month Ultrashort Regimen to Halt Progression From Latent Infection to Active Tuberculosis Among Close Contacts (The TB-YOUTH Study)RecruitingNCT06022146Phase 3
- Sitafloxacin-containing Regimens for Shortening Tuberculosis TreatmentNot yet recruitingNCT05454345Phase 3
- Short-course Rifamycin-based Regimens for Latent Tuberculosis in Patients With End-stage Kidney DiseaseNot yet recruitingNCT05021731Phase 4
- Preventive Treatment Of Latent Tuberculosis Infection In People With Diabetes MellitusRecruitingNCT04600167Phase 3
- Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBIRecruitingNCT03474029Phase 2/3
- Ultra Curto (Ultra Short) TB Prevention TherapyCompletedNCT04703075Phase 4Results posted
- Clofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis: The CLO-FAST StudyTerminatedNCT04311502Phase 2Results posted
- Drug-Drug Interactions Between Rifapentine and Dolutegravir in HIV/LTBI Co-Infected IndividualsTerminatedNCT04272242Phase 2Results posted
- Doravirine, Rifapentine and Isoniazid InteractionCompletedNCT03886701Phase 1Results posted
- Tuberculosis Clinical Trials Consortium Study 35CompletedNCT03730181Phase 1/2Results posted
- Impact of Weekly Administration of Rifapentine and Isoniazid on Steady State Pharmacokinetics of Tenofovir Alafenamide in Healthy Volunteers (YODA)CompletedNCT03510468Phase 1Results posted
- Addiction, HIV and Tuberculosis in Malaysian Criminal Justice SettingsCompletedNCT03089983Not applicableResults posted
- Evaluating PK, Tolerability, and Safety of Rifapentine and Isoniazid in Pregnant and Postpartum WomenCompletedNCT02651259Phase 1/2Results posted
- Pharmacokinetic and Pharmacodynamic Study of High-Dose Rifapentine and Moxifloxacin for Treatment of TuberculosisCompletedNCT02563327Phase 3Results posted
- TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening RegimensCompletedNCT02410772Phase 3Results posted
- Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)CompletedNCT01404312Phase 3Results posted
- Pharmacokinetics, Safety and Tolerability of Escalating Rifapentine Doses in Healthy VolunteersCompletedNCT01162486Phase 1Results posted
- Study of Daily Rifapentine for Pulmonary TuberculosisCompletedNCT00814671Phase 2Results posted
- Rifapentine Plus Moxifloxacin for Treatment of Pulmonary TuberculosisTerminatedNCT00728507Phase 2Results posted
- TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) TreatmentCompletedNCT00694629Phase 2Results posted
- TBTC Study 26 PK: Rifapentine Pharmacokinetics in Children During Treatment of Latent TB InfectionCompletedNCT00164450Not applicableResults posted
- 1HP Versus 3HR in the Treatment of Tuberculosis Infection in VietnamWithdrawnNCT06191692Phase 3
- Safety and Tolerability of 1 Month Daily (1HP) and 3 Months Weekly (3HP) Isoniazid and Rifapentine With Pharmacokinetics of Dolutegravir (DTG) in Pregnant People With HIVActive, not recruitingNCT05122026Phase 1/2
- Evaluation of the Efficacy and Safety of a 4-month Daily Regimen (2HZPM/2HPM) for Treatment of Pulmonary TBActive, not recruitingNCT04856644Phase 3
- Short Course Rifapentine and Isoniazid for the Preventive Treatment for Latent Genital TuberculosisStatus unknownNCT04528277Phase 3
- Risk of SDRs Under 3HP and 1HP Regimen for LTBICompletedNCT04094012Phase 3
- Two-month Regimens Using Novel Combinations to Augment Treatment Effectiveness for Drug-sensitive TuberculosisCompletedNCT03474198Phase 2/3
- Treatment of Latent Tuberculosis in Socially Marginalised CitizensTerminatedNCT03266991Phase 4
- Evaluation of the Effect of 3HP vs Periodic 3HP vs 6H in HIV-Positive IndividualsCompletedNCT02980016Phase 3
- The Correlate of Risk Targeted Intervention StudyStatus unknownNCT02735590Phase 2/3
- PK Interaction Between Rifapentine or Rifampicin and a Single Dose of TMC207 in Healthy Subjects (TMC207-CL002)CompletedNCT02216331Phase 1
- Toward a Safe and Reachable Preventive Therapy for LTBI: a Multicenter Randomized Controlled Study in TaiwanStatus unknownNCT02208427Phase 3
- Interaction Study to Assess the Pharmacokinetic Interaction of Oral Administration of Rifapentine on ATRIPLA™ in HIV PatientsCompletedNCT01690403Phase 1
- Evaluating the Pharmacokinetics of High-Dose Rifapentine When Given as a Single Dose or in Divided Doses to Healthy AdultsCompletedNCT01574638Phase 1
- The Effect of Rifapentine on RaltegravirCompletedNCT00809718Phase 1
- Pharmacokinetic Issues of Moxifloxacin Plus RifapentineTerminatedNCT00460759Phase 1
- Tuberculosis Prevention for HIV Infected AdultsCompletedNCT00057122Phase 3
- TBTC Study 25: Study of the Tolerability of Higher Doses of Rifapentine in the Treatment of TuberculosisCompletedNCT00023426Phase 2
- TBTC Study 25PK: Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-Desacetyl RifapentineCompletedNCT00023387Not applicable
- TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of TuberculosisCompletedNCT00023335Phase 3
- Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia.CompletedNCT00002192Phase 2